Management of Patients with Immune Thrombocytopenia

This OncLive Insights features three immune thrombocytopenia experts who share their approach to treating different patient populations, considerations when selecting treatments, and emerging therapies for this condition.

EP. 1: Treatment of Early Immune Thrombocytopenia (ITP)

January 26th 2022

Drs Bussel and Kessler discuss treatment of early immune thrombocytopenia (ITP).

EP. 2: Debate Regarding Upfront Treatment of Immune Thrombocytopenia

January 26th 2022

ITP experts debate different strategies they use in upfront treatment of ITP.

EP. 3: Immune Thrombocytopenia Treatment, COVID, and Other Vaccinations

February 2nd 2022

Physicians share concerns with ITP medications and response to COVID-19 and other vaccinations.

EP. 4: Role of Splenectomy in Immune Thrombocytopenia Treatment

February 2nd 2022

ITP experts discuss use of splenectomy for treatment of ITP in their practices.

EP. 5: Fostamatinib in Immune Thrombocytopenia

February 9th 2022

Dr Bussel discusses the use of fostamatinib in patients who have progressed on TPO agents.

EP. 6: Treatment of Older Patients With ITP

February 9th 2022

Drs Bussel, Piatek and Kessler discuss treatment of older patients with ITP.

EP. 7: ITP Treatment in Pregnancy

February 16th 2022

ITP experts share considerations in the treatment of pregnant patients with ITP.

EP. 8: Challenges With Diagnosis of ITP

February 16th 2022

Experts discuss lack of consensus in diagnosis of ITP and challenges physicians face.

EP. 9: Sequencing in ITP

February 23rd 2022

Drs Piatek and Bussel discuss sequencing of therapies in ITP.

EP. 10: Experimental Agents for ITP

February 23rd 2022

ITP experts discuss emerging ITP treatment landscape.